drug
(heparin sodium + taurolidine)
Marketedupdated 3mo agoby $CRMD CorMedix Inc.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Nov 15, 2028
~2.2 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Apr 15, 2042compositionUS 11738120
- Apr 15, 2042compositionUS 11738120
- May 16, 2026compositionUS 7696182
- May 16, 2026compositionUS 7696182
FDA exclusivities (4)
- Nov 15, 2033GAINGAIN Antibiotic (5y)
- Nov 15, 2033GAINGAIN Antibiotic (5y)
- Nov 15, 2028NCENew Chemical Entity (5y)2.2y
- Nov 15, 2028NCENew Chemical Entity (5y)2.2y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that